AzTrials
AzTrials

Knee InjuriesNCT04528992

Effects of Blood Flow Restriction (BFR) Therapy on ACL Graft Maturation

A study testing Blood Flow Restriction Therapy and Standard Postoperative Physical Therapy in people with Knee Injuries and Anterior Cruciate Ligament Injuries, run by Stanford University at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This is a study comparing the effects of blood flow restriction (BFR) therapy on the maturation of the Anterior Cruciate Ligament (ACL) graft after reconstruction surgery compared to physical therapy without the use of BFR. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Blood Flow Restriction Therapy and Standard Postoperative Physical Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
20 Sep 2024to 20 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Ages 18 or older, all gender
  • Patients receiving any type of ACL graft, either autograft or allograft, and any type of tissue

Who cannot join

  • Patients who do not meet the the comprehensive BFR screening criteria based on predetermined contraindications and precautions
  • Patients undergoing any additional concomitant ligament repair or reconstruction at the same surgery
  • Revision procedures
  • Patients unable to lay still in an MRI scanner
  • Patients receiving treatment outside Stanford
  • Patients undergoing concomitant meniscus treatment that restricts patients' weight bearing or prolongs their immobilization compared to their surgeons standard postoperative ACL reconstruction protocol
  • Patients who are unable to lay still in an MRI scanner
  • Patients with a torn ACL or previous ACL reconstruction in the contralateral knee

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Stanford

    Redwood City, California, 94063

Other trials in United States

About this study

Official title: Effects of Blood Flow Restriction (BFR) Therapy on Early Anterior Cruciate Ligament (ACL) Graft Maturation

This is a study comparing the effects of blood flow restriction (BFR) therapy on the maturation of the Anterior Cruciate Ligament (ACL) graft after reconstruction surgery compared to physical therapy without the use of BFR.

Read the detailed description

The study will be a randomized controlled trial to compare outcomes between physical therapy with BFR and physical therapy without BFR on the ACL graft maturation following reconstruction surgery. BFR therapy will begin as early as 2 weeks after surgery. The initial 2 weeks after surgery, or prior to initiation of BFR, will consist of the physical therapy following the surgeon's postoperative protocol.

To be considered for participation in this study, patients must be 18 years and older undergoing primary ACL reconstruction. In addition, patients must meet several inclusion/exclusion criteria to be randomized and included in this study.

Being tested
Blood Flow Restriction Therapy, Standard Postoperative Physical Therapy
Medical subject headings
Knee Injuries, Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood Flow Restriction TherapyOther

    BFR is a rehabilitation method that involves wearing a tight band around the exercising extremity to briefly limit blood flow while doing light weight exercises. The response is similar to heavy weight training or lifting but without the stress on the extremity that is still healing from surgery. Will be given after 2 weeks standard postoperative physical therapy per surgeon's ACL reconstruction protocol following surgery.

  • Standard Postoperative Physical TherapyOther

    This is the surgeon's standard postoperative physical therapy protocol after ACL reconstruction.

Study groups in NCT04528992
Study groupRoleWhat they receive
Physical Therapy with BFRExperimentalParticipants will begin BFR therapy as early as 2 weeks after surgery. The initial 2 weeks after surgery, or prior to initiation of BFR will consist of the physical therapy following the surgeon's postoperative protocol.
Receives: Other: Blood Flow Restriction Therapy
Physical Therapy without BFRActive comparatorParticipants will undergo standard physical therapy following the surgeon's postoperative protocol.
Receives: Other: Standard Postoperative Physical Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in MRI imaging of Graft

    Graft ligamentization or maturation on MRI using T2 mapping

    Measured: 2 weeks, 3 months, 6 months

  2. Difference in Quadriceps Volume & Cross-sectional Area

    Quadriceps muscle atrophy measured on MRI with quadriceps cross-sectional area

    Measured: 3 months, 6 months

  3. Difference in Thigh Circumference Measurement

    Muscle measurement determined with measuring tape for thigh circumference

    Measured: 3 months, 6 months

Secondary outcomes (4)
  1. Isokinetic Dynamometer

    Measurement of knee extension and flexion torque at 180° and 300°/sec using the isokinetic dynamometer

    Measured: 2 weeks, 3 months, 6 months

  2. Visual Analog Scale (VAS)

    Patient reported assessment of current level of pain from no pain to worst imaginable

    Measured: 2 weeks, 3 months, 6 months

  3. Single Assessment Numerical Evaluation (SANE)

    Patient reported outcome measure of function. 0-100% scale with 100% being normal

    Measured: 2 weeks, 3 months, 6 months

  4. International Knee Documentation Committee (IKDC)

    Patient reported outcome measure of symptoms, sports activity \& knee function. 0-100 points with 0 (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms)

    Measured: 2 weeks, 3 months, 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Aug 2020
  2. Study start20 Sep 2024
  3. Primary completion20 Sep 2024
  4. Study completion20 Sep 2024

Why it stopped: BFR Physical Therapy Protocol was not finalized and department had multiple similar studies.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04528992
Sponsor's protocol ID
IRB-56716
Status last verified
Nov 2024
First submitted
18 Aug 2020
Last updated
25 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Blood Flow Restriction Therapy and Standard Postoperative Physical Therapy in people with Knee Injuries and Anterior Cruciate Ligament Injuries, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 25 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in MRI imaging of Graft (time frame: 2 weeks, 3 months, 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in